POCT in international development cooperation

  • Sandeep K. Vashist
  • Peter B. Luppa
  • John H. T. Luong


In the Third World, POCT plays an extremely important role in supplying the populations with laboratory medical tests. This chapter describes the preeminent problems within third-world healthcare systems and demonstrates how POCT can also be implemented sensibly within the scope of international development alliances.


  1. 1.
    Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F et al. (2010) Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 363:1005–1015CrossRefPubMedGoogle Scholar
  2. 2.
    Briggs C, Carter J, Lee SH, Sandhaus L, Simon-Lopez R, Vives Corrons JL (2008) ICSH guideline for worldwide point-of-care testing in haematology with special reference to the complete blood count. Int J Lab Med Hem 30:105–116CrossRefPubMedGoogle Scholar
  3. 3.
    Chan CP, Mak WC, Cheung KY, Sin KK, Yu CM, Rainer TH, et al. (2013) Evidence-based point-of-care diagnostics: current status and emerging technologies. Annu Rev Anal Chem 6:191–211CrossRefPubMedGoogle Scholar
  4. 4.
    Hibbeler B, Korzilius H (2010) Globale Gesundheit: Wes Brot ich ess … Dtsch Ärztebl 108: A-138/B-111/ C-111Google Scholar
  5. 5.
    International Diabetes Federation. Diabetes Atlas, Seventh Edition, 2015.
  6. 6.
    Kost GJ (2008) Point of need, global outreach, and a universal companion. Point of Care 7:103–105Google Scholar
  7. 7.
    Martinez AW, Phillips ST, Whitesides GM, Carrilho E (2010) Diagnostics for the developing world: microfluidic paper-based analytical devices. Anal Chem 82:3–10CrossRefPubMedGoogle Scholar
  8. 8.
    NIBIB and India hold joint workshop on low-cost diagnostic and therapeutic medical technologies. Accessed on May 19,2009
  9. 9.
    NIH and India partner to develop low cost medical technologies. Events/Releases/Archiv/2007OctNovDec.Accessed on May 19, 2009
  10. 10.
    Peeling RW, Holmes KK, Mabey D, Ronald A (2006) Rapid tests for sexually transmitted infections (STIs): the way forward. Sex Transm Infect 82 Suppl 5:v1–6CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Vashist SK (2012) Non-invasive glucose monitoring technology in diabetes management: a review. Anal Chim Acta 750:16–27CrossRefPubMedGoogle Scholar
  12. 12.
    Vashist SK, Luppa PB, Yeo LY, Ozcan A, Luong JHT (2015) Emerging technologies for next-generation point-of-care testing. Trends Biotechnol 33(11):692–705CrossRefPubMedGoogle Scholar
  13. 13.
    World Health Organization (2011) The new WHO report on anti-tuberculosis drug resistance: multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response. WHO/HTM/TB/2010.3Google Scholar
  14. 14.
  15. 15.
  16. 16.
  17. 17.

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Sandeep K. Vashist
    • 1
  • Peter B. Luppa
    • 2
  • John H. T. Luong
    • 3
  1. 1.IDS Immunodiagnostic SystemsFrankfurt am MainGermany
  2. 2.Klinikum rechts der TU MünchenInstitut für Klinische Chemie und PathobiochemieMünchenGermany
  3. 3.Research Facility (ABCRF), University College CorkDepartment of Chemistry and Analytical Biological ChemistryCorkIreland

Personalised recommendations